Zusammenfassung
Die Entstehung von Erkrankungen des Herzens und der Gefäße kann mit Hilfe von Risikofaktoren gut erklärt werden. Dieses Konzept ist seit Jahrzehnten bekannt und wird auch in anderen Fachgebieten der Medizin erfolgreich angewandt. Bluthochdruck ist der am häufigsten auftretende Risikofaktor für die Entstehung eines Herzinfarktes in Deutschland. Weitere Risikofaktoren sind zu hohe Blutfette, Diabetes mellitus, bauchbetontes Übergewicht, Bewegungsmangel, falsche Ernährung und das Rauchen. Auch psychosoziale Belastungen (z. B. Stress und fehlende Entspannung) sowie genetische Veranlagung ehöhen das Risiko für einen Herzinfarkt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Assmann G (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105: 310–15
Aune D (2016) BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 353: i2156
Bucksch J (2014) Sitzende Lebensweise als ein gesundheitlich riskantes Verhalten. Dtsch Z Sportmed 65: 15–21
Church T (2007) Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297: 2081–91
Coutinho M (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233–40
D`Agostino R (2008) General Cardiovascular Risk Profile for Use in Primary Care. The Framingham Heart Study. Circulation 117: 743–53
Denollet J (2010) A general propensity to psychological distress affects cardiovascular outcomes: evidence from research on the type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 3: 546–57
Despres J (2001) Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322: 716–20
Deutsche Hochdruckliga e.V. (2013) Leitlinien für das Management der arteriellen Hypertonie. www.hochdruckliga.de
Deutsche Hochdruckliga e.V. (2015)Was können Betroffene gegen Bluthochdruck tun? www.hochdruckliga.de
Doll R (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 328: 1519
EASO (2002) European Association for the Study of Obesity. www.easo.org
European Society of Cardiology (ESC) (2016) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37: 2315–81
European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD) (2013) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Eur Heart J 34: 3035–87
European Society of Hypertension (ESH), European Society of Cardiology (ESC) (2013) Guidelines for the management of arterial hypertension. J Hypertens 31: 1281–1357
Flegal K (2016) Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA 315: 2284–91
Gohlke H (2016) E-Zigaretten-Hype. Kardiologe 10: 23641
Grammer T (2016) Residuales Risiko: Wie wichtig sind High-Density-Lipoproteine und Triglyzeride? Dtsch Med Wochenschr 141: 870–77
Gregg E (2014) Changes in diabetes-related complications in the United States, 1990–2010. NEJM 370: 1514–23
Haffner S (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM 339: 229–34
Horn van L (2014) A diet by any other name is still about energy. JAMA 312: 900–1
Klose G (2014) Familiäre Hypercholesterinämie. Entwicklungen in Diagnostik und Behandlung. Dtsch Ärztebl 111: 523–9
Law M (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338: b1665
Lean M (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311: 158–61
Linden W (1996) Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Int Med 156: 745–52
Linden W (2007) Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 28: 2972–84
Mensink G (2013) Übergewicht und Adipositas in Deutschland. Erste Erhebungswelle der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1) des Robert Koch Instituts. Bundesgesundheitsbl 56: 786–94
Neaton J (1992) Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men. Arch Int Med 152: 56–64
O`Donnell M (2016) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE). Lancet 388: 761–75
Ogden C (2016) Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. JAMA 315: 2292–9
Parhofer K (2016) Therapie von Fettstoffwechselstörungen. Dtsch Ärztebl 113: 261–8
Ravussin E (2005) Physiology. A NEAT way to control weight? Science 307: 530–1
Robert Koch Institut (2015) Hoher Blutdruck: Ein Thema für alle. Gesundheitsberichterstattung, GBE kompakt, Ausgabe 4, 6. Jg
Singh P (2011) The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Diabetes Care 34: 464–7
Stamler J (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284: 311–8
Stampfer M (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. NEJM 343: 16–22
Twig G (2016) Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood. NEJM 374: 2430–40
Weigl J (2016) der Body-Mass-Index macht Schlagzeilen: Wann ist die Mortalitätsrate am niedrigsten? Deutsch Med Wochenschr 141: 1040–41
WHO (2000) World Health Organization. www.who.int
Yusuf S (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet 364: 937–52
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 © Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Mathes, P., Schwaab, B. (2017). Das Risikofaktorenkonzept. In: Ratgeber Herzinfarkt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48020-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-48020-5_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48019-9
Online ISBN: 978-3-662-48020-5
eBook Packages: Medicine (German Language)